These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4551961)

  • 1. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.
    Závadová H; Vonka V; Adam E; Domorázková E; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):43-52. PubMed ID: 4551961
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocytologic study of nasal epithelial cells in influenza.
    Ebisawa IT; Kitamoto O; Takeuchi Y; Makino M
    Am Rev Respir Dis; 1969 Apr; 99(4):507-15. PubMed ID: 4889594
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 5. IMMUNOLOGIC STUDIES OF PURIFIED VIRAL HEMAGGLUTININ.
    TONG MJ; FONG J
    J Immunol; 1964 Jul; 93():35-44. PubMed ID: 14214387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine.
    Marine WM; Stuart-Harris C
    J Pediatr; 1976 Jan; 88(1):26-30. PubMed ID: 1245938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons.
    Woodhour AF; Sweet BH; Tytell AA; Potash L; Stokes J; Weibel RE; Metzgar DP; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):350-61. PubMed ID: 4288225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified influenza virus vaccine. A study of viral reactivity and antigenicity.
    Peck FB
    JAMA; 1968 Dec; 206(10):2277-82. PubMed ID: 5696082
    [No Abstract]   [Full Text] [Related]  

  • 13. The character of interactions of antibodies and inhibitors with influenza virus.
    Kosyakov PN; Rovnova ZI
    Acta Virol; 1969 May; 13(3):179-86. PubMed ID: 4389105
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.
    Schmidt NJ; Lennette EH
    Am J Epidemiol; 1970 Apr; 91(4):351-4. PubMed ID: 4912184
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.
    Wright PF; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jan; 88(1):31-5. PubMed ID: 1245939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of influenza virus neuraminidase in immunity.
    Rott R; Becht H; Orlich M
    J Gen Virol; 1974 Jan; 22(1):35-41. PubMed ID: 4855928
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.